EMA advisors back AbbVie, Celgene, Sanofi and BI drugs

Posted: November 22nd, 2014  |  Company/topic: Celgene
Website:
EMA advisors back AbbVie, Celgene, Sanofi and BI drugs…

EMA advisors back AbbVie Celgene Sanofi and BI drugs

Posted: November 22nd, 2014  |  Company/topic: Celgene
Website:
EMA advisors back AbbVie Celgene Sanofi and BI drugs…

Celgene Receives Positive CHMP Opinion for OTEZLAƂ apremilast the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic Arthritis

Posted: November 21st, 2014  |  Company/topic: Celgene
Website:
Celgene International Srl NASDAQ CELG a whollyowned subsidiary of Celgene Corporation today announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use…

Celgene International S??rl Receives Positive CHMP Opinion For OTEZLA (apremilast), The First Oral PDE4 Inhibitor For The Treatment Of Patients With Psoriasis And Psoriatic Arthritis

Posted: November 20th, 2014  |  Company/topic: Celgene
Website:
Celgene Receives Positive CHMP Opinion for OTEZLA (apremilast), the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic ArthritisBOUDRY, Switzerland--(BUSINESS WIRE)--…